Fri, Oct 24, 2014, 9:34 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. (MACK) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • boogins_00 boogins_00 Oct 13, 2012 10:00 AM Flag

    MACK Should Rise: Yes, but it needs a catalyst

    I hear you but would offer the counter view that the opportunity to purchase a pipeline of five therapeutics---two of which are utterly novel and in one of the hottest areas in cancer therapy---for around seven hundred million is reason unto itself. A great deal of doubt around the new target was put to bed after the ESMO meeting for the new therapeutics, and the 'old line' drugs(MM398 and MM302) are all but slam dunks. They are proven drugs in a new delivery vehicle so the chances of their success are very high.

    So if value means anything to you this is probably a great opportunity. But yes, I agree, most biotech investors are event driven, and until there is some 'hook' moment where herds of folk are convinced simultaneously the price could lag. It would be refreshing to see smart folks line up now and buy before the crush comes----after a positive Phase II trial, an outlicensing deal, a take over attempt(obviously I'm speculating here) etc---and perhaps some will. We'll see.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • SCHEDULE 13G

      Amendment No. 1
      MERRIMACK PHARMACEUTICALS INC
      Common Stock
      Cusip #590328100

      Cusip #590328100

      Item 1: Reporting Person - FMR LLC
      Item 4: Delaware
      Item 5: 33,380
      Item 6: 0
      Item 7: 15,935,258
      Item 8: 0
      Item 9: 15,935,258
      Item 11: 17.003%
      Item 12: HC

      SCHEDULE 13G

      Amendment No. 1
      MERRIMACK PHARMACEUTICALS INC
      Common Stock
      Cusip #590328100

      Cusip #590328100

      Item 1: Reporting Person - FMR LLC
      Item 4: Delaware
      Item 5: 33,380
      Item 6: 0
      Item 7: 15,935,258
      Item 8: 0
      Item 9: 15,935,258
      Item 11: 17.003%
      Item 12: HC

      SCHEDULE 13G

      Amendment No. 1
      MERRIMACK PHARMACEUTICALS INC
      Common Stock
      Cusip #590328100

      Cusip #590328100

      Item 1: Reporting Person - FMR LLC
      Item 4: Delaware
      Item 5: 33,380
      Item 6: 0
      Item 7: 15,935,258
      Item 8: 0
      Item 9: 15,935,258
      Item 11: 17.003%
      Item 12: HC

      SCHEDULE 13G

      Amendment No. 1
      MERRIMACK PHARMACEUTICALS INC
      Common Stock
      Cusip #590328100

      Cusip #590328100

      Item 1: Reporting Person - FMR LLC
      Item 4: Delaware
      Item 5: 33,380
      Item 6: 0
      Item 7: 15,935,258
      Item 8: 0
      Item 9: 15,935,258
      Item 11: 17.003%
      Item 12: HC

 
MACK
9.365+0.245(+2.69%)Oct 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.